Wooree Bio Co.Ltd (082850) - Total Liabilities
Based on the latest financial reports, Wooree Bio Co.Ltd (082850) has total liabilities worth ₩602.31 Billion KRW (≈ $408.18 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Wooree Bio Co.Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Wooree Bio Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Wooree Bio Co.Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Wooree Bio Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Wooree Bio Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ENDURANCE MOTIVE EO -02
F:7VB
|
Germany | €3.88 Million |
|
Australian Vanadium Ltd
AU:AVL
|
Australia | AU$13.62 Million |
|
Inbest Prime VI Inmuebles Socimi SA
MC:YINB6
|
Spain | €24.04K |
|
ENERGY S.P.A.
F:S2I
|
Germany | €21.49 Million |
|
Pakka Limited
NSE:PAKKA
|
India | Rs6.46 Billion |
|
Skyline Builders Group Holding Limited Class A Ordinary Shares
NASDAQ:SKBL
|
USA | $2.56 Million |
|
Ecoplastic Corporation
KQ:038110
|
Korea | ₩1.42 Trillion |
Liability Composition Analysis (2008–2025)
This chart breaks down Wooree Bio Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Wooree Bio Co.Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wooree Bio Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wooree Bio Co.Ltd (2008–2025)
The table below shows the annual total liabilities of Wooree Bio Co.Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩500.57 Billion ≈ $339.23 Million |
+25.87% |
| 2024-12-31 | ₩397.69 Billion ≈ $269.51 Million |
+18.91% |
| 2023-12-31 | ₩334.44 Billion ≈ $226.64 Million |
-11.97% |
| 2022-12-31 | ₩379.92 Billion ≈ $257.47 Million |
-25.42% |
| 2021-12-31 | ₩509.39 Billion ≈ $345.21 Million |
-4.78% |
| 2020-12-31 | ₩534.95 Billion ≈ $362.53 Million |
+3.55% |
| 2019-12-31 | ₩516.64 Billion ≈ $350.12 Million |
-0.10% |
| 2018-12-31 | ₩517.18 Billion ≈ $350.48 Million |
+6.99% |
| 2017-12-31 | ₩483.40 Billion ≈ $327.60 Million |
-29.83% |
| 2016-12-31 | ₩688.87 Billion ≈ $466.84 Million |
-12.06% |
| 2015-12-31 | ₩783.30 Billion ≈ $530.83 Million |
+41.78% |
| 2014-12-31 | ₩552.46 Billion ≈ $374.39 Million |
+33.72% |
| 2013-12-31 | ₩413.13 Billion ≈ $279.97 Million |
+86.89% |
| 2012-12-31 | ₩221.06 Billion ≈ $149.81 Million |
+18.48% |
| 2011-12-31 | ₩186.58 Billion ≈ $126.44 Million |
-61.39% |
| 2010-12-31 | ₩483.19 Billion ≈ $327.45 Million |
+34.94% |
| 2009-12-31 | ₩358.09 Billion ≈ $242.67 Million |
+35.84% |
| 2008-12-31 | ₩263.61 Billion ≈ $178.65 Million |
-- |
About Wooree Bio Co.Ltd
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; surface mounting technology products; separators for secondary batteries; backlight parts for thin film transistor-liquid crystal displays; sells and assembles TVs; and TV and LCD monitor components. In addition, it pro… Read more